dilated cardiomyopathy 3B
dilated cardiomyopathy 3B
Explore linked clinical trials. Standard reference: MONDO:00105422 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age | dilated cardiomyopathy 3B | Not yet recruiting | Phase 2 | 2025-08-15 | NCT06643442 | |
| Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy | dilated cardiomyopathy 3B | Recruiting | Phase 1 | 2025-02-27 | NCT06224660 |